Chris Chiang

Chris Chiang is an experienced professional in project management and strategic outsourcing, currently serving as Sr. Manager in the Project Management Office at Revolution Medicines since August 2024. Prior to this role, Chris held the position of Sr. Program and Portfolio Manager at Sangamo Therapeutics, Inc. from January 2022 to January 2024, and worked as a Senior Strategic Outsourcing Manager at Genentech from January 2020 to January 2022. Chris began a career in project management at SRI International, where tenure lasted from January 2017 to January 2020. Additionally, Chris co-founded APP312, contributing from January 2016 to January 2017. Chris holds a Bachelor of Science in Biology from UC San Diego.